Buenavista, Maura E.

HRN: 20-72-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2024
04/11/2024
IV
4.5gm
QID
Lung Abscess
Waiting Final Action 
04/09/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2024
04/09/2024
IVT
500mg
Q8
T/c Lung Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: